Rare diseases
Investigational molecules
Locations
Back to Slovakia231 clinical trials in Kosice, Slovakia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
SlovakiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
SlovakiaStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
SlovakiaStudy of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels
SlovakiaStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
SlovakiaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
SlovakiaStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
SlovakiaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
SlovakiaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
SlovakiaStudy on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis
SlovakiaStudy of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
SlovakiaStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on chronic respiratory conditions, including studies evaluating new treatments for COPD and uncontrolled asthma. Trials are examining novel therapeutic approaches to improve patient outcomes and quality of life.
Research includes evaluation of medications like tezepelumab for COPD and AZD8630 for asthma control.
Comprehensive studies addressing cardiovascular health and metabolic conditions, from heart failure prevention to lipid disorders management.
Current trials are exploring innovative combinations of medications for cardiovascular risk reduction and metabolic control.
Advanced research into inflammatory and autoimmune disorders, including studies on Crohn's disease, ulcerative colitis, and Sjögren's syndrome.
Trials are evaluating novel biological treatments and targeted therapies for various autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
